Status:
UNKNOWN
The Population Pharmacokinetics of Montelukast in Infants and Children
Lead Sponsor:
Shandong University
Conditions:
Asthma
Eligibility:
All Genders
1-12 years
Brief Summary
The investigators' aim was to evaluate the population pharmacokinetics of montelukast in infants and children and define the appropriate dose in order to optimize Montelukast treatment in this vulnera...
Eligibility Criteria
Inclusion
- patients have been diagnosed with asthma; age range: 1 month to 12 years old; montelukast used as part of regular treatment.
Exclusion
- expected survival time less than the treatment cycle; patients with other factors that researcher considers unsuitable for inclusion.
Key Trial Info
Start Date :
October 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2018
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03238560
Start Date
October 1 2016
End Date
June 1 2018
Last Update
August 3 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shandong Provincial Qianfoshan Hospital
Ji'nan, Shandong, China, 250014